Two physicians assert that pharmaceutical companies' sponsorship of clinical conferences for residents and physicians represent a conflict of interest.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
The author describes some of the diverse training paths that may lead to becoming a bioethicist and how the breadth of this field is useful in exploring many ethical questions in the field of medicine.